cord

King’s College London Researchers Unveil Experimental Spinal Cord Injury Drug KCL-286 as a Novel Multi-Target Strategy for Alzheimer’s Disease Therapy

In a significant development for neurodegenerative research, scientists at King’s College London have identified a promising therapeutic candidate that could…